Partners in the Continuum of Drug Development

Exclusive episode of the “Empowered Patient Podcast” with Gabriele Brambilla, CEO and Executive VP of Alira Health

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

This show covers a variety of cutting-edge topics, including the emergence of precision medicine and breakthroughs in genomics, using big data from wearables and sensors, and transparency in the medical marketplace.

Gabriele Brambilla, CEO and Executive VP of Alira Health, joined “Empowered Patient Podcast” latest episode “Partners in the Continuum of Drug Development” to speak about our mission of humanizing healthcare, Alira Health’s latest acquisitions, and how we engage and partner with patients throughout the delivery of our services to our clients.

We call it democratization of life sciences research, the ability to use our technology to directly involve patients, in different phases of development of a drug or a device, in a very active partnership, not just a passive collection of data."
Gabriele Brambilla CEO and Executive Vice President of AliraHealth


Listen to the episode “Partners in the Continuum of Drug Development” below or check it out on the following platforms:

Would you like to learn how Alira Health’s full spectrum of services can help you transform healthcare?

Related news

News November 15, 2022
Alira Health Partners with Policy Matters to Foster Market Access in the UK
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist(...)
Digital Health Healthcare Consulting Market Access
News November 10, 2022
Alira Health and GDMH together to boost Life Sciences innovation
The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.
Clinical Trials Digital Health DTx Market Access Real-World Evidence RWE
Multimedia October 27, 2022
RARECast: Leveraging Technology to Empower Patients and Decentralize Clinical Trials
Technology plays a central role in the future of patient empowerment and decentralized clinical trials. Listen to the podcast to learn more.
Decentralized Clinical Trials MedTech
News October 4, 2022
Alira Health enhances its market access services through a strategic partnership with Centivis
Alira Health, a global healthcare advisory and technology company, announced a strategic partnership with Centivis AG, a boutique market access consulting agency, specializing in digital(...)
Digital Health Market Access MedTech Pharma Regulatory
Events September 30, 2022
XV Congresso Nazionale Sihta
We are pleased to share that we will be joining as speakers and sponsors XV Congresso Nazionale Sihta, a key event for Italian Healthcare industry.
Digital Health Real-World Evidence
Publications September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
Events September 6, 2022
EADV Congress 2022
We are pleased to share that our team will be attending EADV Congress 2022 in Milan this September. EADV Congress is an outstanding educational and learning experience for dermatologists(...)
Decentralized Clinical Trials Digital Therapeutics Real-World Evidence
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.